Skip to main content
HCPCS J1580 · Level II · Part B drug

J1580: garamycin (Gentamicin Sulfate), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J1580

Billing unit
80 MG
Garamycin gentamicin inj
ASP payment limit
$1.849
October 2026; -4.0% vs July 2026
Practitioner MUE
9
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J1580 is the Level II code for Injection, garamycin, gentamicin, up to 80 mg, billed per 80 MG. The Medicare Part B ASP payment limit for October 2026 is $1.849 per billing unit, down 4.0% from July 2026. The practitioner MUE allows up to 9 units per date of service (MAI 3), so a full 9-unit day is $16.64 at the current limit. Under OPPS it carries status indicator N. J1580 is billed in units of 80 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 21 NDCs to it, sold as Gentamicin Sulfate by Hikma Pharmaceuticals USA Inc., Baxter Healthcare Corporation, Henry Schein Inc. No current Billing and Coding Article lists J1580, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J1580 at $1.849 per 80 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $1.925 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J1580
QuarterPayment limitPerCoinsurance
October 2026$1.84980 MG20%
July 2026$1.92580 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 21 NDCs from 7 labelers to J1580. Report the NDC in the claim's drug segment and bill the number of J1580 units that equals the quantity administered divided by 80 MG; the last column gives units per full package.

NDCs that crosswalk to J1580
NDCDrug nameLabelerPackage sizeBilling units / package
00143-9128-25Gentamicin SulfateHikma Pharmaceuticals USA Inc.2 × 2525
00338-0503-48Gentamicin SulfateBaxter Healthcare Corporation100 × 11
00338-0505-48Gentamicin SulfateBaxter Healthcare Corporation100 × 12
00338-0507-41Gentamicin SulfateBaxter Healthcare Corporation50 × 11
00338-0507-48Gentamicin SulfateBaxter Healthcare Corporation100 × 12
00338-0509-41Gentamicin SulfateBaxter Healthcare Corporation50 × 11
00338-0511-41Gentamicin SulfateBaxter Healthcare Corporation50 × 12
00404-9865-02Gentamicin SulfateHenry Schein Inc.2 × 11
00404-9866-20Gentamicin SulfateHenry Schein Inc.20 × 110
00409-1207-03Gentamicin SulfatePfizer Inc2 × 2525
51662-1508-03Gentamicin SulfateHF Acquisition Co. LLC, DBA HealthFirst20 × 25250
51662-1597-03Gentamicin SulfateHF Acquisition Co. LLC, DBA HealthFirst2 × 2525
55150-0401-25Gentamicin SulfateEugia US LLC2 × 2525
55150-0402-25Gentamicin SulfateEugia US LLC2 × 2525
55150-0403-25Gentamicin SulfateEugia US LLC20 × 25250
63323-0010-02Gentamicin SulfateFreseniUS Kabi USA, LLC2 × 2525
63323-0010-20Gentamicin SulfateFreseniUS Kabi USA, LLC20 × 25250
63323-0010-94Gentamicin SulfateFreseniUS Kabi USA, LLC2 × 2525
63323-0010-95Gentamicin SulfateFreseniUS Kabi USA, LLC20 × 25250
63323-0173-02Gentamicin SulfateFreseniUS Kabi USA, LLC2 × 2525
63323-0173-94Gentamicin SulfateFreseniUS Kabi USA, LLC2 × 2525

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J1580. For practitioners the limit is 9 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J1580 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services93 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital93 Date of Service Edit: ClinicalPrescribing Information
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J1580 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J1580 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J1580 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J1580 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J1580 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J1580 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J1580 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J1580 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J1580

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J1580

What does HCPCS code J1580 describe?

J1580 is defined by CMS as "Injection, garamycin, gentamicin, up to 80 mg". Each billing unit represents 80 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J1580 a CPT code?

No. J1580 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as garamycin (Gentamicin Sulfate); CPT codes are five-character codes maintained by the AMA. On a Part B claim J1580 reports the drug itself in 80 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J1580 in October 2026?

The ASP-based payment limit is $1.849 per 80 MG, with 20% beneficiary coinsurance. The July 2026 limit was $1.925. Commercial payers use their own fee schedules.

How many units of J1580 can be billed per day?

The practitioner Medically Unlikely Edit is 9 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J1580?

The October 2026 ASP crosswalk lists 21 NDCs from 7 labelers: Gentamicin Sulfate (Hikma Pharmaceuticals USA Inc.); Gentamicin Sulfate (Baxter Healthcare Corporation); Gentamicin Sulfate (Henry Schein Inc.); Gentamicin Sulfate (Pfizer Inc). For example NDC 00143-9128-25 (package size 2) equals 25 billing units of J1580.

Does J1580 have NCCI bundling edits?

No active practitioner PTP pairs list J1580 as a column-1 or column-2 code in the v323r0 release.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.